Antibe Therapeutics Inc.
ATBPF
$0.2156
$0.025613.47%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18.86M | 20.61M | 25.91M | 28.74M | 31.29M |
| Total Receivables | 476.30K | 532.20K | 472.00K | 546.90K | 1.15M |
| Inventory | 1.05M | 955.10K | 1.22M | 574.30K | 202.50K |
| Prepaid Expenses | 197.60K | 215.90K | 237.10K | 164.10K | 226.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 694.40K | 679.40K | 694.00K | 676.30K | 28.10K |
| Total Current Assets | 21.27M | 22.99M | 28.53M | 30.71M | 32.90M |
|
|
|||||
| Total Current Assets | 21.27M | 22.99M | 28.53M | 30.71M | 32.90M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 19.95M | 19.48M | 19.90M | 19.48M | 19.47M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.45M | 2.04M | 2.05M | 1.97M | 2.11M |
| Total Assets | 42.68M | 44.51M | 50.47M | 52.15M | 54.48M |
|
|
|||||
| Total Accounts Payable | 2.12M | 2.12M | 3.33M | 2.04M | 2.09M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.12M | 2.12M | 3.33M | 2.04M | 2.09M |
|
|
|||||
| Total Current Liabilities | 2.12M | 2.12M | 3.33M | 2.04M | 2.09M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 20.92M | 20.43M | 20.87M | 20.42M | 20.42M |
| Total Liabilities | 23.04M | 22.54M | 24.20M | 22.46M | 22.51M |
|
|
|||||
| Common Stock & APIC | 122.04M | 118.82M | 121.44M | 118.55M | 118.18M |
| Retained Earnings | -110.17M | -104.44M | -102.91M | -96.45M | -93.79M |
| Treasury Stock & Other | 7.77M | 7.59M | 7.75M | 7.59M | 7.58M |
| Total Common Equity | 19.64M | 21.96M | 26.28M | 29.69M | 31.97M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 19.64M | 21.96M | 26.28M | 29.69M | 31.97M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 19.64M | 21.96M | 26.28M | 29.69M | 31.97M |
|
|
|||||
